ABOBOTULINUMTOXINA
Plantar Fasciitis
University Foot and Ankle Foundationprotein_peptidePhase 2Dormant
CC
47/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 32/ 100
- Competitive Position
- 95/ 100
Competitive context
1 Active assets in the Plantar Fasciitis cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
DEHYDRATED HUMAN AMNION/CHORION MEMBRANE (DHACM) MiMedx Group, Inc. | Phase 3 | BBB |
N-Acetyl-L-Cysteine University of Arizona | Phase 2 | CCC |
Same molecule, other indications
ABOBOTULINUMTOXINA is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →